CCR2 and atherosclerosis: Finally, anti-CCR2 adjunctive therapy decreased atherosclerosis lesions of BCG-infected INH/RIF-treated mice, while also decreasing plaque size and lipid content.<h4>Conclusions</h4>Monocyte activation and atherosclerosis burden remained elevated after BCG clearance with antimicrobials.